1-[2'-hydroxy-3'-(1H-pyrrolo[3,2-c]pyridin-2-yl)-biphenyl-3-ylmethyl]-3-pyridin-2-yl-urea

ID: ALA209772

Chembl Id: CHEMBL209772

PubChem CID: 23646873

Max Phase: Preclinical

Molecular Formula: C26H21N5O2

Molecular Weight: 435.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1cccc(-c2cccc(-c3cc4c[nH]ccc-4n3)c2O)c1)Nc1ccccn1

Standard InChI:  InChI=1S/C26H21N5O2/c32-25-20(7-4-8-21(25)23-14-19-16-27-12-10-22(19)30-23)18-6-3-5-17(13-18)15-29-26(33)31-24-9-1-2-11-28-24/h1-14,16,27,32H,15H2,(H2,28,29,31,33)

Standard InChI Key:  YDGGWOFXJUYFDS-UHFFFAOYSA-N

Associated Targets(Human)

F3 Tclin Coagulation factor III (225 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor VII and X (116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin and coagulation factor VII (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F7 Tchem Coagulation factor VII/tissue factor (740 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.49Molecular Weight (Monoisotopic): 435.1695AlogP: 5.27#Rotatable Bonds: 5
Polar Surface Area: 102.93Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.92CX Basic pKa: 4.31CX LogP: 4.82CX LogD: 4.80
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.30Np Likeness Score: -1.07

References

1. Riggs JR, Hu H, Kolesnikov A, Leahy EM, Wesson KE, Shrader WD, Vijaykumar D, Wahl TA, Tong Z, Sprengeler PA, Green MJ, Yu C, Katz BA, Sanford E, Nguyen M, Cabuslay R, Young WB..  (2006)  Novel 5-azaindole factor VIIa inhibitors.,  16  (12): [PMID:16621549] [10.1016/j.bmcl.2006.03.049]

Source